Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTIMAL LEAP: Optimizing Preventive Treatment Intervals for Malaria to Advance Longitudinal Learning, Executive Function, Attendance, and Pathways

NCT07798583 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT07798583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07798583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTIMAL LEAP: Optimizing Preventive Treatment Intervals for Malaria to Advance Longitudinal Learning, Executive Function, Attendance, and Pathways
Lead sponsor
Indiana University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 1, 2028
Completion date
January 1, 2033
Enrollment
1,500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic malaria, intermittent preventive treatment, malaria